Montana Code 50-32-606. Designation of patient — instruction
50-32-606. Designation of patient — instruction. (1) A prescription issued pursuant to 50-32-604 or 50-32-605 must designate the eligible recipient as the patient, regardless of the eligible recipient’s status as an individual, organization, agency, or other entity. Except as provided in 50-32-605, the prescription must be dispensed by a licensed pharmacy.
Terms Used In Montana Code 50-32-606
- Department: means the department of public health and human services provided for in 2-15-2201. See Montana Code 50-32-603
- dispensing: has the meaning provided in 37-7-101. See Montana Code 50-32-603
- Eligible recipient: means :
(a)a person who is at risk of experiencing an opioid-related drug overdose;
(b)a family member, friend, or other person who is in a position to assist a person who is at risk of experiencing an opioid-related drug overdose;
(c)a first responder or a first responder entity;
(d)a harm reduction organization or its representative;
(e)the Montana state crime laboratory or its representative;
(f)a person who, on behalf of or at the direction of a law enforcement agency or officer, may process, store, handle, test, transport, or possess a suspected or confirmed opioid;
(g)a probation, parole, or detention officer;
(h)a county or other local public health department or its representative; or
(i)a veterans' organization or its representative. See Montana Code 50-32-603
- Opioid antagonist: means a drug that binds to opioid receptors and blocks or inhibits the effects of opioids acting on those receptors. See Montana Code 50-32-603
- Opioid-related drug overdose: means an acute condition evidenced by symptoms, including but not limited to physical illness, pinpoint pupils, coma, decreased level of consciousness, or respiratory depression, resulting from the consumption or use of an opioid or another substance with which an opioid is combined. See Montana Code 50-32-603
- Practitioner: means :
(a)a physician, dentist, veterinarian, scientific investigator, or other person licensed, registered, or otherwise permitted to distribute, dispense, or conduct research with respect to or to administer a dangerous drug in the course of professional practice or research in this state;
(b)a pharmacy or other institution licensed, registered, or otherwise permitted to distribute, dispense, or conduct research with respect to or to administer a dangerous drug in the course of professional practice or research in this state; and
(c)a physician licensed to practice medicine or a dentist licensed to practice dentistry in another state. See Montana Code 50-32-101
- Prescription: means an order given individually for the person for whom prescribed, directly from the prescriber to the furnisher or indirectly to the furnisher, by means of an order signed by the prescriber and bearing the name and address of the prescriber, the prescriber's license classification, the name of the patient, the name and quantity of the drug or drugs prescribed, the directions for use, and the date of its issue. See Montana Code 50-32-101
(2)A licensed pharmacy or medical practitioner dispensing an opioid antagonist shall provide the patient with basic instruction and information, the content of which must be developed by the department and made publicly available on the department’s website, concerning recognition of the signs and symptoms of an opioid-related drug overdose, indications for the administration of an opioid antagonist, administration technique, and the need for immediate and long-term followup to the administration of the opioid antagonist, including calling 9-1-1.
(3)An eligible recipient described in 50-32-603(5)(c) through (5)(i) who distributes an opioid antagonist pursuant to 50-32-607 shall:
(a)fulfill the basic instruction and information requirements set forth in subsection (2); and
(b)develop protocol for:
(i)instructing and training the eligible recipient’s employees or other authorized personnel that is consistent with the instruction and information developed by the department under subsection (2); and
(ii)the storage, maintenance, and location of the opioid antagonist.